Autolus Therapeutics plc·4

Jul 1, 4:13 PM ET

Iannone Robert 4

4 · Autolus Therapeutics plc · Filed Jul 1, 2026

Research Summary

AI-generated summary of this filing

Updated

Autolus (AUTL) Director Robert Iannone Receives Equity Awards

What Happened

  • Director Robert Iannone received two award grants on June 29, 2026 totaling 79,167 derivative equity awards (31,667 and 47,500 units). The reported acquisition price for both grants is $0.00, so no cash was paid at grant; the reported value at grant is $0 (derivative awards).
  • The filing (Form 4) was submitted on July 1, 2026 disclosing the June 29, 2026 awards.

Key Details

  • Transaction date: 2026-06-29; Form 4 filed: 2026-07-01 (timely filing indicated).
  • Awards: 31,667 and 47,500 derivative awards; total 79,167.
  • Price/Value: $0.00 per award as reported (derivative grant).
  • Vesting/terms (per footnotes):
    • Some awards are Restricted Stock Units (RSUs): each RSU is a contingent right to one American Depositary Share (ADS), and each ADS is convertible into one ordinary share (Footnote F1). RSUs vest in one installment on June 29, 2027 (F2).
    • Some awards are share options that vest in twelve equal monthly installments beginning July 29, 2026 (F3).
  • Shares owned after the transaction: not specified in the provided filing details.

Context

  • These are grant/award transactions (code A) — derivative awards that give the holder future exposure to company shares if vesting and other conditions are met. They are not open-market purchases or sales, and do not by themselves indicate the insider bought or sold shares.
  • RSUs convert to ADSs (and then to ordinary shares) upon vesting; options (if any in this grant package) will vest over 12 months per the footnote. Retail investors should note vesting timelines when assessing potential future dilution or insider incentives.

Insider Transaction Report

Form 4
Period: 2026-06-29
Transactions
  • Award

    Restricted Share Units

    [F1][F2]
    2026-06-29+31,66731,667 total
    American Depositary Shares (31,667 underlying)
  • Award

    Share Option (Right to Buy)

    [F3]
    2026-06-29+47,50047,500 total
    Exercise: $1.61Exp: 2036-06-29American Depositary Shares (47,500 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's American Depositary Shares. Each American Depositary Share is convertible at any time at the option of the Reporting Person into one Ordinary Share.
  • [F2]The RSUs vest in one installment on June 29, 2027.
  • [F3]Share options vest in twelve equal monthly installments commencing on July 29, 2026.
Signature
/s/ Robert Iannone|2026-07-01

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT